Literature DB >> 17429006

Iron chelation and regulation of the cell cycle: 2 mechanisms of posttranscriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion.

Dong Fu1, Des R Richardson.   

Abstract

Iron (Fe) plays a critical role in proliferation, and Fe deficiency results in G(1)/S arrest and apoptosis. However, the precise role of Fe in cell-cycle control remains unclear. We observed that Fe depletion increased the mRNA of the universal cyclin-dependent kinase inhibitor, p21(CIP1/WAF1), while its protein level was not elevated. This observation is unique to the G(1)/S arrest seen after Fe deprivation, as increased p21(CIP1/WAF1) mRNA and protein are usually found when arrest is induced by other stimuli. In this study, we examined the posttranscriptional regulation of p21(CIP1/WAF1) after Fe depletion and demonstrated that its down-regulation was due to 2 mechanisms: (1) inhibited translocation of p21(CIP1/WAF1) mRNA from the nucleus to cytosolic translational machinery; and (2) induction of ubiquitin-independent proteasomal degradation. Iron chelation significantly (P < .01) decreased p21(CIP1/WAF1) protein half-life from 61 (+/- 4 minutes; n = 3) to 28 (+/- 9 minutes, n = 3). Proteasomal inhibitors rescued the chelator-mediated decrease in p21(CIP1/WAF1) protein, while lysosomotropic agents were not effective. In Fe-replete cells, p21(CIP1/WAF1) was degraded in an ubiquitin-dependent manner, while after Fe depletion, ubiquitin-independent proteasomal degradation occurred. These results are important for considering the mechanism of Fe depletion-mediated cell-cycle arrest and apoptosis and the efficacy of chelators as antitumor agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429006     DOI: 10.1182/blood-2007-03-076737

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.

Authors:  Lawrence D Horwitz; Marcus A Horwitz
Journal:  Antioxid Redox Signal       Date:  2014-06-20       Impact factor: 8.401

3.  Enterobactin, an iron chelating bacterial siderophore, arrests cancer cell proliferation.

Authors:  Piu Saha; Beng San Yeoh; Xia Xiao; Rachel M Golonka; Sivarajan Kumarasamy; Matam Vijay-Kumar
Journal:  Biochem Pharmacol       Date:  2019-06-19       Impact factor: 5.858

4.  Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells.

Authors:  Victoria I Holden; Steven Lenio; Rork Kuick; Sadeesh K Ramakrishnan; Yatrik M Shah; Michael A Bachman
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

5.  "Function-first" lead discovery: mode of action profiling of natural product libraries using image-based screening.

Authors:  Christopher J Schulze; Walter M Bray; Marcos H Woerhmann; Joshua Stuart; R Scott Lokey; Roger G Linington
Journal:  Chem Biol       Date:  2013-02-21

6.  The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.

Authors:  Sharleen V Menezes; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

7.  Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation.

Authors:  Michael Roth; Britta Will; Guillermo Simkin; Swathi Narayanagari; Laura Barreyro; Boris Bartholdy; Roni Tamari; Constantine S Mitsiades; Amit Verma; Ulrich Steidl
Journal:  Blood       Date:  2012-05-24       Impact factor: 22.113

8.  CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.

Authors:  Ling Li; Kang Huang; Huijia Zhao; Binyao Chen; Qifa Ye; Jiang Yue
Journal:  Cell Cycle       Date:  2020-04-10       Impact factor: 4.534

9.  The iron chelator Dp44mT causes DNA damage and selective inhibition of topoisomerase IIalpha in breast cancer cells.

Authors:  V Ashutosh Rao; Sarah R Klein; Keli K Agama; Eriko Toyoda; Noritaka Adachi; Yves Pommier; Emily B Shacter
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

10.  Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia.

Authors:  Celine Callens; Séverine Coulon; Jerome Naudin; Isabelle Radford-Weiss; Nicolas Boissel; Emmanuel Raffoux; Pamella Huey Mei Wang; Saurabh Agarwal; Houda Tamouza; Etienne Paubelle; Vahid Asnafi; Jean-Antoine Ribeil; Philippe Dessen; Danielle Canioni; Olivia Chandesris; Marie Therese Rubio; Carole Beaumont; Marc Benhamou; Hervé Dombret; Elizabeth Macintyre; Renato C Monteiro; Ivan C Moura; Olivier Hermine
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.